References
-
1
Conway CR, Sheline YI, Chibhall JT, George MS, Fletcher JW, Mintuu MA.
Cerebral blood flow changes during vagus nerve stiumulation for depression.
Psychiatry Res.
2006;
146
179-184
-
2
Knoch D, Treyer V, Regard M, Muri RM, Buck A, Weber B.
Lateralized and frequency dependent effects of prefrontal rTMS on regional cerebral blood flow.
Neuroimage.
2006;
21
1053-8119
-
3
Nemeroff CB, Mayberg HS, Krahl SE, Mc Namara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK.
VNS therapy in Treatment-resistant Depression. Clinical evidence and putative neurobiological mechanisms. Neurobiological Mechanisms.
Neuropsychopharmacolcogy.
2006;
31
1345-1355
-
4
Pogarell O, Koch W, Popperl G, Tatasch K, Jakob F, Zwanzger P, Mullert C, Rupprecht R, Moller HJ, Hegerl H, Padberg F.
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression. Preliminary results of a dynamic [(123I)] IBZM SPECT study.
J Psychiatry Res.
2006;
40
307-314
-
5
Sackheim HA, Rush AJ, Marangell CB, Husain MM, Nahas Z, Johnson CR, Seidmann S, Giller C, Haines S, Goodmann RR.
Vagus nerve stimulation (VNS) for treatment - resistant depression: efficiacy, side effects and predictors of outcome.
Neuropsychopharmacology.
2001;
25
713-728
-
6
Schrader LM, Stern JM, Fields TA, Nuwer MR, Wilson CL.
A lack of effect from trancranial magnetic stimulation (TMS) on the vagus nerve stimulation (VNS).
Clin Neurophysiol.
2005;
116
2501-2504
-
7
Yukimasa T, Yoshima R, Uozumi T, Shinkai K, Ueda N, Tsuji S, Nakamura J.
High frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain derived neurotrophic factor.
Pharmacopsychiatry.
2006;
39
52-59
Correspondence
W. Sperling
Psychiatrische Universitätsklinik·Universität Erlangen-Nürnberg
Schwabachanlage 6
91054 Erlangen
Telefon: +49/9131/853 61 94
Fax: +49/9131/853 41 01
eMail: wolfgang.sperling@uk-erlangen.de